Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 12
2006 9
2007 7
2008 12
2009 10
2010 12
2011 7
2012 6
2013 7
2014 4
2015 10
2016 22
2017 18
2018 13
2019 12
2020 8
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

161 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean wang gang zhang (79 results)?
Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.
Liu YF, Wang BY, Zhang WN, Huang JY, Li BS, Zhang M, Jiang L, Li JF, Wang MJ, Dai YJ, Zhang ZG, Wang Q, Kong J, Chen B, Zhu YM, Weng XQ, Shen ZX, Li JM, Wang J, Yan XJ, Li Y, Liang YM, Liu L, Chen XQ, Zhang WG, Yan JS, Hu JD, Shen SH, Chen J, Gu LJ, Pei D, Li Y, Wu G, Zhou X, Ren RB, Cheng C, Yang JJ, Wang KK, Wang SY, Zhang J, Mi JQ, Pui CH, Tang JY, Chen Z, Chen SJ. Liu YF, et al. EBioMedicine. 2016 Jun;8:173-183. doi: 10.1016/j.ebiom.2016.04.038. Epub 2016 May 13. EBioMedicine. 2016. PMID: 27428428 Free PMC article.
Management of cytokine release syndrome related to CAR-T cell therapy.
Chen H, Wang F, Zhang P, Zhang Y, Chen Y, Fan X, Cao X, Liu J, Yang Y, Wang B, Lei B, Gu L, Bai J, Wei L, Zhang R, Zhuang Q, Zhang W, Zhao W, He A. Chen H, et al. Among authors: zhang w. Front Med. 2019 Oct;13(5):610-617. doi: 10.1007/s11684-019-0714-8. Epub 2019 Sep 28. Front Med. 2019. PMID: 31571160
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma.
Zhao WH, Liu J, Wang BY, Chen YX, Cao XM, Yang Y, Zhang YL, Wang FX, Zhang PY, Lei B, Gu LF, Wang JL, Yang N, Zhang R, Zhang H, Shen Y, Bai J, Xu Y, Wang XG, Zhang RL, Wei LL, Li ZF, Li ZZ, Geng Y, He Q, Zhuang QC, Fan XH, He AL, Zhang WG. Zhao WH, et al. J Hematol Oncol. 2018 Dec 20;11(1):141. doi: 10.1186/s13045-018-0681-6. J Hematol Oncol. 2018. PMID: 30572922 Free PMC article. Clinical Trial.
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study.
Zhang L, Meng L, Liu B, Zhang Y, Zhu H, Cui J, Sun A, Hu Y, Jin J, Jiang H, Zhang X, Li Y, Liu L, Zhang W, Liu X, Gu J, Qiao J, Ouyang G, Liu X, Luo J, Jiang M, Xie X, Li J, Zhao C, Zhang M, Yang T, Wang J. Zhang L, et al. Among authors: zhang w. Clin Cancer Res. 2021 Jan 1;27(1):70-77. doi: 10.1158/1078-0432.CCR-20-1600. Epub 2020 Sep 14. Clin Cancer Res. 2021. PMID: 32928796
Th17 cells: positive or negative role in tumor?
Ji Y, Zhang W. Ji Y, et al. Among authors: zhang w. Cancer Immunol Immunother. 2010 Jul;59(7):979-87. doi: 10.1007/s00262-010-0849-6. Epub 2010 Mar 30. Cancer Immunol Immunother. 2010. PMID: 20352428 Review.
161 results